- 2 inmates sue state over hepatitis C treatment Updated: May-27-15 7:20 am
MINNEAPOLIS - Two prisoners who have hepatitis C are suing the Minnesota Department of Corrections because they want access to expensive new drug treatments.
- Shiprock boy with genetic condition gets liver transplant Updated: May-25-15 3:01 pm
FARMINGTON, New Mexico - A 2-year-old Shiprock boy who suffers from a rare genetic condition recently received a liver transplant in California.
- Indiana approves 1st needle-exchange program under new law Updated: May-21-15 4:41 pm
INDIANAPOLIS - Indiana approved a yearlong needle-exchange program Thursday for a rural county at the center of an HIV outbreak that spurred a new state law allowing such programs to curb the spread of diseases among intravenous drug users.
- N. Dakota urging residents to get tested for hepatitis C Updated: May-19-15 2:05 am
BISMARCK, North Dakota - The North Dakota Health Department is encouraging residents to undergo testing for hepatitis C.
- Gilead lifted by $3.6B 1Q sales of newest hepatitis C pill Updated: Apr-30-15 5:20 pm
FOSTER CITY, California - Gilead Sciences raked in $3.6 billion from sales of its newest hepatitis C pill, lifting the drugmaker's results past Wall Street expectations.
- New meds help drugmakers weather strong dollar, other issues Updated: Apr-28-15 4:50 pm
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because they're purchased in local currencies, the strong dollar is depressing the sales' value.